376
Participants
Start Date
January 4, 2019
Primary Completion Date
August 21, 2019
Study Completion Date
September 4, 2019
Ibrexafungerp
Ibrexafungerp 300 mg BID for 1 day
Placebo
Matching placebo
Unified Women's Clinical Research- Hagerstown, Hagerstown
Group For Women, Norfolk
Unified Women's Clinical Research - Lyndhurst Clinical Research, Winston-Salem
Unified Women's Clinical Research Greensboro, Greensboro
Unified Women's Clinical Research Raleigh, Raleigh
GYN Center for Women PA, Durham
Carolina Women's Research and Wellness Center, Durham
Unified Women's Clinical Research, Morehead City
Medical Research South, Charleston
Magnolia Ob/Gyn Research Center, LLC, Myrtle Beach
New Age Medical Research Corporation, Miami
Altus Research, Lake Worth
Women's Medical Research Group, Clearwater
OBGYN Assoc of Mid Florida, Leesburg
University of Alabama at Birmingham, Birmingham
Medical Research Center of Memphis, Memphis
Wayne State University, Detroit
Consultants In Women's Healthcare, Inc., St Louis
Clinical Trials Management LLC, Covington
Clinical Trials Management LLC, Metairie
TMC Life Research Inc, Houston
Precision Trials AZ, LLC, Phoenix
Womens' Health Care Research Corp, San Diego
Center For Women's Health and Wellness LLC - Interspond - PPDS, Lawrenceville
Lawrence OB/GYN Clinical Research, LLC, Lawrenceville
Scynexis, Inc.
INDUSTRY